Tessa Therapeutics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tessa Therapeutics Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11016
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that discovers, develops, and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response and identify and exterminate cancer cells. The company provides products for cancers including gastric carcinoma, cervical, nasopharyngeal, lung, head, oropharyngeal, and neck cancer. It harnesses virus-specific T cell (VST) technology for the treatment of solid tumors. Tessa Therapeutics is also extending its VST platform and treat an array of solid tumors through combinatorial approaches with chimeric antigen receptors, antibodies, and oncolytic virus technologies. The company works in partnership with National Cancer Centre, Singapore; Baylor College of Medicine; and Agency for Science, Technology and Research. Tessa Therapeutics is headquartered in Singapore.

Tessa Therapeutics Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Tessa Therapeutics Raises Additonal USD50 Million in Financing 10
Tessa Therapeutics Raises USD80 Million in Financing 11
Partnerships 12
St. Jude Children’s Research Hospital and Tessa Therapeutics Enter into Partnership 12
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 13
Tessa Therapeutics and Vyriad Enter into Agreement 14
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 15
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 16
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 17
Licensing Agreements 18
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 18
Acquisition 19
Tessa Therapeutics Acquires Euchloe Bio 19
Tessa Therapeutics Pte Ltd – Key Competitors 20
Tessa Therapeutics Pte Ltd – Key Employees 21
Tessa Therapeutics Pte Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Dec 12, 2017: Tessa Therapeutics Appoints Mr. Desmond Lim as Chief Financial Officer 23
Jul 20, 2017: Tessa Therapeutics Appoints Ms. Jennifer Butler as Chief Commercial Officer 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tessa Therapeutics Pte Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tessa Therapeutics Raises Additonal USD50 Million in Financing 10
Tessa Therapeutics Raises USD80 Million in Financing 11
St. Jude Children's Research Hospital and Tessa Therapeutics Enter into Partnership 12
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 13
Tessa Therapeutics and Vyriad Enter into Agreement 14
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 15
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 16
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 17
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 18
Tessa Therapeutics Acquires Euchloe Bio 19
Tessa Therapeutics Pte Ltd, Key Competitors 20
Tessa Therapeutics Pte Ltd, Key Employees 21
Tessa Therapeutics Pte Ltd, Subsidiaries 22

List of Figures
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tessa Therapeutics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務情報
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Nishimatsu Construction Co Ltd (1820):企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co Ltd (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Medical Properties Trust, Inc.:企業のM&A・事業提携・投資動向
    Medical Properties Trust, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medical Properties Trust, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Faes Farma SA (FAE):企業の財務・戦略的SWOT分析
    Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dow Silicones Corp:企業の戦略的SWOT分析
    Dow Silicones Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Edisun Power Europe AG (ESUN):企業の財務・戦略的SWOT分析
    Summary Edisun Power Europe AG (Edisun Power) is a solar power producer. The company finances, develops and operates solar power plants in various European countries. It offers technical studies, legal and financial studies, custom design, installation, work monitoring, and operation and maintenance …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corporation Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Trinity Exploration and Production plc (TRIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Trinity Exploration and Production plc (Trinity), formerly Bayfield Energy Holdings plc is an oil and gas company that explores and develops onshore and offshore projects. The company’s activities include production, development, exploration and extraction of hydrocarbons. It operates in Tri …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Novanta Inc (NOVT):医療機器:M&Aディール及び事業提携情報
    Summary Novanta Inc (Novanta), formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam de …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Consolidated Edison Development Inc:電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison Development Inc (CED), a subsidiary of Consolidated Edison Inc, is an energy company that develops, owns and operates renewable and energy infrastructure projects. The company operates solar photovoltaic projects and wind farms. It operates energy storage and energy pipel …
  • Arcbest Corp.
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Industrial Bank Of Korea
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Marriott Vacations Worldwide Corporation:企業の戦略・SWOT・財務情報
    Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Lockheed Martin Corp:企業の戦略・SWOT・財務情報
    Lockheed Martin Corp - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Gulf Cement Company PSC:企業の戦略・SWOT・財務情報
    Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report Summary Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆